Bristol-Myers Squibb Company
Income Statement
| Line Item | FY2009 | FY2008 | FY2007 |
|---|---|---|---|
| Revenue | $18.81B | $17.72B | $15.62B |
| Cost of Revenue | $5.14B | $5.32B | $4.92B |
| Gross Profit | $13.67B | $12.40B | $10.70B |
| Gross Margin | 72.7% | 70.0% | 68.5% |
| Operating Expenses | |||
| Research & Development | $3.65B | $3.51B | $3.16B |
| SG&A Expense | $3.95B | $4.14B | $3.94B |
| Operating Income | $5.79B | $5.09B | $2.52B |
| Operating Margin | 30.8% | 28.7% | 16.2% |
| Interest Expense | $184.0M | $310.0M | — |
| Pretax Income | $5.60B | $4.78B | $2.52B |
| Income Tax Expense | $1.18B | $1.09B | $471.0M |
| Net Income | $10.61B | $5.25B | $2.17B |
| Net Margin | 56.4% | 29.6% | 13.9% |
| EPS (Basic) | $5.35 | $2.64 | $1.09 |
| EPS (Diluted) | $5.34 | $2.62 | $1.09 |
| Shares Outstanding (Basic) | 1.97B | — | — |
| Shares Outstanding (Diluted) | 1.98B | — | — |
| Dividends Per Share | $1.25 | $1.24 | $1.15 |